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Abstract – Classical scrapie has proved to be a notoriously diﬃcult disease to control due to a poor un-
derstanding of its natural history. The recognition of disease risk linkage to PrP genotype has oﬀered the
prospect of a disease control strategy, viz. genotyping and selective breeding, novel to veterinary medicine
when first considered in the 1990s. The UK Spongiform Encephalopathy Advisory Committee recom-
mended the exploitation of this approach in a voluntary, national programme to control classical scrapie
and protect the public against food-borne exposure to bovine spongiform encephalopathy, should the na-
tional flock have been exposed via contaminated feed. The National Scrapie Plan for Great Britain was
launched in 2001 and uptake has been widespread throughout the purebreeding sector of the sheep industry,
with membership peaking at over 12 000 flocks in 2006. A total of 700 000 rams from 90 breeds have
been genotyped. A comparison of ram lambs born in 2002 with those in 2006 shows evident changes in
PrP genotype frequencies which are predicted to be associated with a reduction in disease risk. Various
concerns have been raised regarding possible unintended consequences of widespread selection on PrP
genotype, including impacts on other performance traits and possible eﬀects on inbreeding and genetic di-
versity. To date, these concerns appear to be unfounded, as no consistent associations have been found with
performance traits, nor are there likely to be any detectable impacts on inbreeding in mainstream breeds.
Currently, semen banks have been implemented in Great Britain to store samples from animals of all com-
mon PrP genotypes, should these genotypes be required in the future. Various strategies to minimise future
disease risks are discussed in the paper.
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1. INTRODUCTION: THE ISSUES WITH
SCRAPIE CONTROL
Classical scrapie is a fatal neurodegenera-
tive disease of sheep and goats that has been
endemic in Britain for at least three cen-
turies [29] and is also recognised in many
of the sheep-rearing countries of the world:
notable exceptions are Australia and New
Zealand. It has been classified as a single
disease entity within the group of diseases
known as the transmissible spongiform en-
cephalopathies (TSE), or prion diseases. How-
ever, the known spectrum of prion diseases of
small ruminants has been extended recently
with the recognition of previously undescribed
variants, e.g., Nor 98 and atypical scrapie (AS)
[1, 4, 5, 23, 27, 32].
Historically, classical scrapie has proved to
be a diﬃcult disease to control. A poor un-
derstanding of the aetiology, pathogenesis, and
epidemiology has severely limited options for
disease control. The failure to identify a con-
ventional micro-organism as the aetiological
agent has meant that the development of di-
rect or indirect diagnostic assays for use in
live sheep and goats has been a relatively
barren area of applied research. Biopsy of ac-
cessible lymphoid tissue e.g., tonsil [33], third
eyelid [28], and lymphoid tissue associated
with rectal mucosa [16], followed by assay
for prion protein do oﬀer options for preclin-
ical diagnosis and can be applied routinely to
suspect single cases, or small groups of ani-
mals. However, cost, practicality, and welfare
considerations inhibit widespread application
at the flock level. Routinely, therefore, recog-
nition of infected sheep is normally achieved
after the emergence of clinical signs and using
diagnostic assays on brain and tissue samples
collected following post mortem examination.
Restrictions on disease control options caused
by the availability of limited diagnostics are
further compounded by poor knowledge of
the routes of transmission. Infected ewes may
disseminate infection via uterine discharges,
contaminating the lambing environment, more
than once in a prolonged period of clinical
latency: peak age incidence for scrapie is 2–
4 years, but a significant minority of cases
occur in older sheep.
The potential for PrP genotyping to con-
trol scrapie started to emerge in the 1990s
when case control studies [20] demonstrated
clear linkage between classical scrapie dis-
ease risk and PrP genotype in several breeds
of sheep in Britain. The significant polymor-
phisms linked to disease risk are at codons
136 (alanine/valine), 154 (arginine/histidine),
and 171 (glutamine/histidine/arginine) of the
ovine PrP gene. Combinations of these poly-
morphisms lead to five commonly seen PrP
haplotypes or alleles (Tab. I). PrP genotyping
was made available to sheep farmers in Britain
in the early 1990s to aid selection of rams for
breeding. One of the first breeds to benefit was
the Swaledale [10], a hill breed from the north
of England with a history of endemic classi-
cal scrapie in which previous studies [9] had
strongly indicated a genetic predisposition to
experimental challenge.
The impetus to control disease at a national
level increased dramatically from the mid-
1990s, for two main reasons: the emergence
of variant CJD [40] and the demonstration that
BSE could be transmitted to sheep by the oral
route [15]. More farmers started to have their
sheep PrP, or “scrapie”, genotyped as they
recognised the benefits that this novel tool pre-
sented. Tested rams of certain genotypes could
be purchased with more confidence, knowing
that there was little risk of them developing
future classical scrapie disease, or increas-
ing disease risk in their progeny. In the UK,
an advisory group, the Scrapie Information
Group, comprising government oﬃcials, sci-
entists, veterinarians, and industry members,
published guidelines on the use and interpre-
tation of genotyping results [11]. The concern
that the national flock might have been ex-
posed to BSE via contaminated sheep feed
prompted the Government’s Spongiform En-
cephalopathy Advisory Committee to recom-
mend a control programme based on PrP geno-
typing. Modelling studies by the Veterinary
Laboratories Agency [2] showed that genotyp-
ing focussed on purebred ram lambs, followed
by selective breeding, would have the great-
est impact on disseminating classical scrapie
resistance, so reducing the risk of classical
scrapie in the national flock. Based on this
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Table I. The 15 PrP genotypes and their allocation to risk groups. Rams are awarded a certificate according
to genotype. The use of types 1, 2 and 3 rams is not restricted. Type 4 and 5 rams are required to be culled
or castrated.
Genotype NSP Group Associated scrapie risk
ARR/ARR 1 Very low
ARR/AHQ
ARR/ARH
ARR/ARQ
2 Low
AHQ/AHQ
AHQ/ARH
AHQ/ARQ
ARH/ARH
ARH/ARQ
ARQ/ARQ
3 Moderate, especially in ARQ/ARQ
ARR/VRQ 4 Moderate
AHQ/VRQ
ARH/VRQ
ARQ/VRQ
VRQ/VRQ
5 High, especially in ARQ/VRQ and VRQ/VRQ
NSP: National Scrapie Plan.
modelling, the National Scrapie Plan (NSP)
for Great Britain was launched in July 2001
with the twin aims of controlling classical
scrapie and protecting the consumer from the
exposure to BSE via sheep meat, should the
national flock have become infected.
In addition to its adoption in the UK, the
broad strategy of attempting to control clas-
sical scrapie based on PrP genotype selection
has been adopted to a greater or lesser ex-
tent in several European Countries – notably
The Netherlands from 1998, France, and Eire.
Programmes have also been operated in North
America. There has been considerable varia-
tion in scheme application. In terms of pos-
itive selection for the ARR allele, the Dutch
scheme seems to have been the most aggres-
sive: it was designed with the aim of producing
50 000 ARR homozygote rams by 2004 to
enable production of “safe” lamb for the con-
sumer. In France, the strategy has been to
target elite selection flocks. In Eire, the choice
of animals to genotype has been left more to
the discretion of the breeder.
European Commission Decision 2003/100/
EC provided for the introduction of EU-wide
genotype-based breeding programmes on a
voluntary basis from 2004 and then on a com-
pulsory basis from 1 April 2005. However,
the European Parliament and the Council of
Ministers expressed reservations, in particular
about the risk of adverse impacts on genetic di-
versity and on rare and locally adapted breeds.
The requirement for all member states to adopt
compulsory breeding programmes was there-
fore dropped. It was left to the discretion of
each member state whether or not to pursue
voluntary schemes.
The aim of this paper is to describe and
discuss progress and limitations of selection
on PrP genotype. As a case study it con-
siders the extent to which selection on PrP
genotype under the auspices of the NSP
(www.defra.co.uk/nsp) has been successful in
Great Britain, as measured by scheme uptake,
numbers of rams tested and the resulting an-
nual changes in genotype profiles and allele
frequencies. It then briefly considers possible
impacts on other performance traits, inbreed-
ing, risks of classical scrapie epidemics, and
the potential prevalence of other forms of
scrapie. It also briefly describes measures that
are currently being taken to safeguard against
future risks, through the development of a se-
men archive containing semen straws from all
major susceptible PrP genotypes.
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Figure 1. Annual progression in flock membership
(number of flocks) of the National Scrapie Plan
(NSP) Ram Genotyping Scheme.
2. THE NATIONAL SCRAPIE PLAN FOR
GREAT BRITAIN
The Ram Genotyping Scheme (RGS) has
been the main element of the NSP. This is
a voluntary programme, introduced in 2001,
with all costs – blood sampling, electronic
identification, laboratory genotyping, supply
of certificates, and scheme administration –
met by government. Members have been en-
titled to annual sampling visits at which all
rams and ram lambs have been genotyped, ir-
respective of whether they are participating
in structured breed improvement programmes.
Each of the 15 PrP genotypes (i.e. pairings of
the five alleles defined by the polymorphisms
at codons 136, 154, and 171) have been as-
signed to one of five groups, according to the
risk of disease in the individual and in first
generation progeny (Tab. I) [39].The plan re-
quires negative selection of the VRQ allele and
encourages positive selection for the ARR al-
lele. Rams with the VRQ allele have to be
killed or castrated.
3. UPTAKE OF THE NSP
A productive working relationship was es-
tablished from the outset with the National
Sheep Association and the majority of its con-
stituent breed societies. This cooperation re-
sulted in widespread uptake of the RGS by
sheep breeders, which is illustrated in Figure
1. The numbers of ram lambs tested annually
are given at Figure 2. Given that the average
working life of a ram in Britain is 4–5 years
and there are estimated to be 400 000 rams
used each year in Britain [30], it seems proba-
ble that the majority of working rams will have
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Figure 2. Numbers of ram lambs genotyped each
year, from 2002 to 2006.
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Figure 3. The frequency (%) distribution of Na-
tional Scrapie Plan (NSP) genotype groupings (see
Tab. I) of ram lambs tested in the NSP for 2002 and
2006.
been genotyped by now. Flock membership of
the scheme has steadily risen and peaked at
over 12 000 flocks, a figure estimated to repre-
sent 80% of flocks producing breeding rams.
More than 700 000 rams from 90 diﬀerent
breeds have been genotyped.
4. IMPACT OF THE RAM GENOTYPING
SCHEME ON GENOTYPE PROFILES
AND ALLELE FREQUENCY
To monitor the progress of the RGS, the
genotype profiles and allele frequencies have
been assessed for successive populations of
ram lambs sampled each year and also for each
of the major breeds [39]. Figure 3 illustrates
the shift in genotype profile of all ram lambs
that has been achieved from 2001 to 2006.
Type 1 genotypes have increased from 28.8%
to 47.6%; type 2 genotypes have remained
around the 40% level; type 3 genotypes have
shown a reduction from 24.9% to 9.4%, and
for the VRQ-carrying genotypes, types 4 and
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Table II. Changes in allele frequencies, comparing
the 2002 cohort of ram lambs with that of 2006.
Allele 2002 2006 Percentage change
ARR 50.4 68.8 + 36.5
AHQ 7.4 5.5 – 25.7
ARH 9.9 5.6 – 43.4
ARQ 29.2 18.9 – 35.3
VRQ 3.0 1.2 – 60.0
5, the reduction is from 5.9% to 2.3%. The
shift in allele frequencies is recorded in Ta-
ble II. The changes recorded for the tested ram
lambs have been: an increase in the frequency
of the ARR allele from 50.4% to 68.8%, a
relative increase of 36.5%; a reduction in the
frequency of the ARQ allele from 29.2% to
18.9%, a relative reduction of 35.3%; a reduc-
tion in the frequency of the VRQ allele from
3% to 1.2%, a relative reduction of 60%. As
the changes in allele frequencies will be pro-
gressively reflected in the ewes bred by these
rams, it is to be expected that the risk of classi-
cal scrapie in the national flock will diminish,
as described below.
In addition to the RGS, which has aimed
to reduce disease risk across the national
flock, control action has also been targeted at
known aﬀected flocks to reduce the risk of
further disease transmission. Approximately
200 farmers with cases occurring between to
1998 and 2004 volunteered to attempt control
based on genotyping, selective culling of at-
risk genotypes and subsequent breeding with
low risk genotypes. Furthermore, an additional
250 holdings with cases occurring since 2004
have been subject to the compulsory control
measures – genotype and cull, or whole flock
cull – as required by EC regulation 999/2001
as amended. In these 450 holdings, there has
been as yet only a single case of further dis-
ease in a type 2 ewe in low-risk sheep selected
for retention for further breeding.
EU TSE regulation 999/2001 as amended
requires EU member states to conduct surveil-
lance of fallen stock over 18 months of age
and ewes over 18 months of age submitted
to abattoirs for evidence of scrapie. In Great
Britain there are positive signs from these sur-
veys that the prevalence of infection is falling.
In 2003, the prevalence figures for the abat-
toir survey and fallen stock survey were 0.06%
and 0.23%, respectively. In 2006, these preva-
lences had fallen to 0.02% and 0.17%. There
is also a notable downward trend in the annual
incidence of disease as measured by cases con-
firmed following on-farm reports of suspected
disease: 403 such cases were recorded in 2002,
compared to 99 in 20061. However, these lat-
ter statistics have to be interpreted with caution
as they may be influenced by whether or not
farmers report all suspect cases.
The reduction in the detection rates for
scrapie indicated by the various surveillance
routes are encouraging, but further epidemi-
ological analysis is required to determine to
what extent the trend can be attributed to com-
bined eﬀects of the RGS and/or the control
measures that have been targeted at known af-
fected flocks.
Whilst addressing concerns over classical
scrapie, large-scale industry-wide selection of
animals on PrP genotype, raises many impor-
tant issues, including those that cloud the in-
dustry perception of the breeding scheme and
which may impede voluntary uptake. These
issues include possible impacts on other per-
formance traits, eﬀects on inbreeding and ge-
netic diversity in commercial populations, the
prevalence of other forms of scrapie and the
actual rate at which risks of classical scrapie
are predicted to decline. However, most of
these issues have been recognised by both in-
dustry and scientists, and are being addressed
in parallel with breeding programmes based on
PrP genotype.
5. EFFECT OF PrP SELECTION ON OTHER
PERFORMANCE TRAITS
There are a number of ways in which selec-
tion on PrP genotype may impact upon other
commercially important performance traits.
For example, there may be a direct impact of
the PrP gene on other traits of interest, such as
lamb survival or growth rate, or aspects of ma-
ternal performance. Secondly, there may well
be genes influencing performance traits that
1 Del Rio Vilas V.J., Personal communication.
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are genetically linked with the PrP on chro-
mosome 13, i.e. in close vicinity to the PrP
locus. Therefore specific alleles at these genes
will tend to be inherited as a unit along with
the PrP alleles. This can be disadvantageous if
the linkage phase is such that the favourable
alleles are inherited along with undesirable
PrP alleles, but it can be advantageous if the
linkage phase is reversed and the favourable
performance trait alleles are inherited with
favourable PrP alleles. Linkage phase can be
expected to diﬀer between populations, even
between families in some instances, so that as-
sociations that are beneficial in one population
may be deleterious in another. A third way that
PrP selection can impact on performance traits
is simply through the opportunity cost of di-
verting selection pressure away from traits that
are normally selected on. In this case, a decline
in performance traits is not expected; rather,
the rate of gain will be reduced.
Associations between PrP genotype and
performance are covered in detail by Sweeney
and Hanrahan [37]. As a general summary, al-
though some associations have been observed
between PrP genotype and performance traits,
these tend not to be strong, nor are they con-
sistent between populations. Also, there is no
discernable tendency for published associa-
tions between scrapie-resistant PrP alleles and
performance traits to be adverse. From these
published studies it is not generally possi-
ble to distinguish between direct (pleiotropic)
eﬀects of PrP genotype and eﬀects due to link-
age. For example, Moore et al.2 compared
eﬀects of PrP genotype on lamb performance
traits in three major British Hill breeds, the
Welsh Mountain, North Country Cheviot, and
Scottish Blackface. Breed-specific eﬀects that
were seen included (i) 0.38 kg higher birth
weights in North Country Cheviot AHQ/AHQ
lambs relative to other genotypes (p < 0.01),
(ii) 0.5 kg higher 8 week weights in VRQ
heterozygous Scottish Blackface lambs rela-
tive to non-carriers (p < 0.01) and (iii) a
decrease in ultrasonic scanning weight associ-
2 Moore R.C., Boulton K., Bishop S.C., Associa-
tions of PrP genotype with lamb production traits
in three commercial hill sheep breeds (manuscript
in preparation).
ated with the ARR allele in Welsh Mountain
lambs (p < 0.001). The absence of a common
eﬀect across the three breeds suggests that the
associations are probably due to breed spe-
cific alleles of neighbouring genes in linkage
disequilibrium with the PrP locus. However,
chance associations, i.e. false positives, can
not be ruled out.
Perhaps the only biologically explicable ef-
fect that has been detected to date in British
studies, is an association between PrP geno-
type and coat colour patterns in primitive
British breeds3. This can readily be explained
by the Agouti locus which has a major influ-
ence on coat colour and patterns; this locus
is closely linked to the PrP gene on chromo-
some 13. Therefore, it may be hypothesized
that the apparent PrP coat colour eﬀects are
due to linkage disequilibrium between specific
agouti and PrP alleles.
Opportunity cost eﬀects associated with se-
lection on PrP genotype have been explored in
some detail by Man et al. [24]. In these simu-
lation studies, it was assumed that flocks that
were selecting on PrP genotype were already
a part of a breeding programme in which in-
tensive selection was being performed on a
performance trait. Diverting selection pressure
towards PrP genotype may well result in a de-
crease in the genetic progress made in other
traits, although the impact is probably some-
what less than expected by many. The losses
in genetic progress are a function of overall
population size, PrP allele frequencies and se-
lection strategies. If selection is against the
VRQ allele only, then almost no impact is seen
on genetic progress in other traits. An impact
is seen if selection is for the ARR allele, but
only when this allele is at a low frequency. For
example, selection aimed at fixing the ARR
allele in 15 years, in a population typical of
a mainstream British Terminal sire breed, was
predicted to result in a loss of ca. 2 years in ge-
netic progress in performance traits, with most
of this loss occurring early in the selection pro-
3 Bell L., Goodman T., Martin J.H. et al., Survey of
scrapie PrP genotype results and their relationships
with coat colour and hornedness in selected UK rare
sheep breeds, Proceedings of the British Society of
Animal Science, 2004, p. 124.
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cess when most of the selection pressure was
placed on increasing ARR frequency. This re-
sult was for a starting ARR frequency of 0.3,
if it was higher, then the reductions in gain
in performance traits were less. In most main-
stream British breeds ARR allele frequencies
are now relatively high, and in some cases
ARR is the most common allele. It should be
noted that although Man et al. [24] considered
the case of performance traits, the same argu-
ments would apply if breeders were selecting
for other attributes such as breed type charac-
teristics.
6. EFFECT OF PrP SELECTION
ON INBREEDING AND GENETIC
DIVERSITY
Possible impacts on inbreeding and genetic
diversity, i.e. increased inbreeding, population
bottlenecks and decreased diversity, are of-
ten cited as a possible negative consequence
of intense selection on PrP genotype. Again,
consideration of precisely what PrP-based se-
lection does is required. At the genetic level,
selection is being performed on a genotype
at one location on one autosome, out of 26
autosomes. Therefore, a marked reduction in
genetic diversity can be expected at the PrP lo-
cus and in the immediate vicinity of this locus,
but not elsewhere in the genome. At the pop-
ulation level, a decreased eﬀective population
size, and ultimately an increased rate of in-
breeding, may possibly be expected if the PrP
selection strategy forces the breeders to use
fewer sire families than they would otherwise
have done, or if similar total number of sires
are used, but a small number (e.g. ARR/ARR
rams) are used to a much greater extent than
rams of other genotypes.
Possible eﬀects of PrP selection on ge-
netic diversity and/or inbreeding have been
assessed using actual data arising from PrP-
based selection programmes4 and also from
simulation studies [24]. Palhière et al. studied
4 Palhière I., Brochard M. et al., Did the selection
for scrapie resistance impact genetic variability?
Preliminary results on four French sheep breeds, 8th
World Congress on Genetics Applied to Livestock
Production, 2006, Communication 31-10.
genetic marker and geneological data arising
from large scale French breeding programmes
based on PrP genotype. Specifically, she as-
sessed genetic marker heterozygosity on five
microsatellite markers linked to PrP on chro-
mosome 13, and 24 markers elsewhere in the
genome. Further, using pedigree data she esti-
mated the eﬀects on population structure and
dynamics. In terms of genetic marker proper-
ties, a large impact was seen on heterozygosity
and the number of alleles present for markers
linked to PrP, but only trivial impacts else-
where in the genome. The population dynam-
ics, as assessed by coeﬃcients of relationship
between individual animals, and the number of
ancestors contributing 50% of the genes were
largely unchanged. In other words, intense
selection on PrP genotype did not markedly
change genetic diversity or expected inbreed-
ing rates. Given that selection on PrP genotype
must focus selection on a small number of
families that otherwise might not have been
selected, why does it not therefore lead to po-
tential inbreeding problems? The answer lies
in the fact that directed selection for perfor-
mance traits, in itself, is already a source of
potential inbreeding. Redirecting some selec-
tion towards PrP genotype is, at worst, simply
substituting one form of inbreeding for an-
other. It may even be beneficial if it forces the
breeder to use a wider range of families than
would otherwise have been used.
These conclusions were reinforced by the
modelling studies of Man et al. [24]. As de-
scribed above, these studies investigated the
dynamics of partial PrP-based selection in an
ongoing breeding programme. In addition to
having only small impacts on rates of gain on
performance traits, it was found that rates of
inbreeding were either the same as, or lower
than, situations where selection was on per-
formance traits. Thus it may be concluded
that provided eﬀective population sizes are not
small, and eﬀorts are made to avoid the mat-
ing of close relatives, then selection on PrP
genotype will not have a deleterious impact on
inbreeding. This assumes that breeders were
previously positively selecting for improved
animals, and not simply seeking to minimize
inbreeding.
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These conclusions diﬀer in situations where
population sizes are very small, for example in
rare or endangered breeds where the eﬀective
population size is less than, e.g., 50 animals. In
this case there may be very few animals con-
taining desirable PrP genotypes, and selective
breeding on PrP may well cause unacceptable
population bottlenecks. In this case, selection
based on PrP genotype may not be a feasible
option.
7. RISKS OF SCRAPIE EPIDEMICS
The ultimate aim of the PrP breeding pro-
gramme is to reduce the incidence of classical
scrapie, i.e. the risk that an epidemic occurs
and the severity of the epidemic should it
occur. Given the presence of the infectious
agent in some flocks, clearly these risks are
a function of the genotype profile of the pop-
ulation and the relative susceptibilities of the
individual genotypes in the population, along
with other non-genetic risk factors. Relative
risks of classical scrapie for diﬀerent geno-
types may be deduced from data on cases of
scrapie observed in commercial sheep, along
with knowledge of the genotype distribution of
the sheep populations from which these cases
were reported. For example, Baylis et al. [3]
reported an analysis of population-wide clas-
sical scrapie prevalence data and deduced the
expected number of cases per million sheep.
The ARQ/ARQ genotype may be used as the
baseline, and 37 cases per million were re-
ported for this genotype. Other notable results
were zero case per million for ARR/ARR
sheep, and 225, 405, and 545 cases per million
for ARQ/VRQ, ARH/VRQ, and VRQ/VRQ
genotypes, respectively. All other genotypes
had fewer than ten cases per million. Tongue
et al. [38] performed a similar analysis, ex-
pressing relative risks as odd ratios, and came
to broadly similar conclusions.
The data from Baylis et al. [3] were then
used in modelling studies [18], which as-
sume transmission of infection through direct
contact, to assess the impact of selection on
PrP genotype on scrapie prevalence and inci-
dence. Such selection strategies were indeed
predicted to be successful in reducing the
prevalence and incidence of disease, though
there was likely to be a delay of several years
between the implementation of a breeding pro-
gramme and the reduction in incidence. As
may be expected from the high relative risks
incurred by having the VRQ allele, the major
factor reducing scrapie risks was the elimina-
tion of the VRQ allele.
Several cautions should be applied to these
results. Firstly, the results presented by Gub-
bins and Roden [18] are average or expected
results. In reality, there will be variability
of outcomes, with diﬀerent outcomes arising
in diﬀerent flocks by chance alone. Detailed
simulations which incorporate the stochastic
nature of likely epidemic risks have been un-
dertaken by Man5 et al. These results show
that even in cases where the population-wide
prevalence of classical scrapie may be very
low, often there are individual flocks where
risks remain high. Therefore, it is very dif-
ficult to guarantee that PrP-based selection
will eliminate classical scrapie from the na-
tional population. Secondly, these results as-
sume transmission by direct contact; therefore
elimination of infectious animals will elimi-
nate the transmission of classical scrapie. This
may not be the case if there are environmen-
tal reservoirs of infection. Such reservoirs may
act as a source of infection into the future,
and hence prolong the risks of scrapie. Thirdly,
transmission was estimated as a function of
the relative risk of classical scrapie, in turn es-
timated from the number of cases of clinical
scrapie. This does not allow for the possi-
bility that “resistant” animals may in fact be
subclinically infected animals that are nev-
ertheless transmitting infection. These latter
two caveats would benefit from investigation
through mathematical modelling studies. Al-
though it is likely that their impacts on clas-
sical scrapie risks will be small, in relation to
the major eﬀect of eliminating the VRQ allele,
they should nevertheless be investigated.
8. EFFECTS ON OTHER FORMS
OF SCRAPIE
This paper has concentrated so far on PrP
genotype in relation to classical scrapie. How-
ever, other forms of scrapie also exist. For
5 Manuscript in preparation.
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example, a new type of scrapie, currently de-
scribed as atypical scrapie, has been observed
in many countries and its PrP genetics are dif-
ferent from those of classical scrapie [1, 4,
23,27,32]. A recently described PrP polymor-
phism on the ARQ allele at codon 141 (L/F),
plays a major role in susceptibility and the ani-
mals most at risk are of genotypes AHQ/AHQ,
AF141RQ/AF141RQ and AF141RQ/AHQ. In
contrast to classical scrapie, ARR/ARR sheep
are susceptible to atypical scrapie, although
often it remains a subclinical disease with min-
imal PrPSc accumulation. Further, the VRQ
allele does not incur extreme susceptibility to
atypical scrapie as it does for classical scrapie.
Although it is clearly evident that selection on
PrP genotype, i.e. eliminating the VRQ allele
and increasing the ARR frequency, will not
be successful against atypical scrapie, calcu-
lations based on the relative risks of diﬀerent
genotypes suggest that this selection will be
neutral regarding atypical scrapie (Baylis et
al., personal communication). In other words,
it will neither increase nor decrease risks of
atypical scrapie.
More generally, concern arises from the
observations on atypical scrapie along with
numerous mouse studies that there may not
be a universally scrapie resistant PrP geno-
type. Rather, it is widely believed that the
outcome of an exposure depends upon the
specific pairing of TSE strain and host PrP
genotype. This eﬀect can be substantial: in
some circumstances a genotype considered re-
sistant to one strain can be highly susceptible
to another. This is important because substan-
tial strain variation occurs in mouse scrapie,
and it has also been demonstrated in surveys
of field scrapie in sheep [8].
Lessons can be taken from the mouse where
incubation period is also governed by TSE
strain [13], as well as PrP genotype, as il-
lustrated by large diﬀerences in incubation
time (range ca. 150–460 days) within a single
strain of inbred PrP A encoding mice chal-
lenged with diﬀerent TSE strains [7].Further,
challenge of PrP A encoding C57BL mice
with mouse adapted scrapie strain Me7 re-
sults in incubation periods of ca. 160 days
whilst identical challenges of PrP B encod-
ing mice have longer incubation periods, ca.
360 days. Conversely, following challenge of
the same mouse strains with mouse adapted
sheep scrapie strain 22A the incubation time
ranking is reversed such that PrP B mice may
develop scrapie at ca. 190 days whilst PrP A
mice take up to 480 days to develop clinical
scrapie [6, 7]. Thus, high or low susceptibility
to TSE is not a fixed property of any given PrP
genotype but the outcome of a specific pairing
of host PrP genotype and TSE strain proper-
ties.
The concern arising from these findings is
that whilst classical scrapie is currently the
predominant strain present in populations con-
taining large numbers of ARQ alleles accom-
panied by a low but significant proportion of
VRQ alleles, this need not be the case in the
future. There is a possible risk that as the sheep
population genotype profile changes, then new
forms of scrapie may arise that are adapted
to the new predominant genotypes. This could
potentially undermine current PrP selection
strategies and is clearly a topic for further
study, particularly as the likely prevalence and
infectivity of non-classical forms of scrapie
are unknown. In this regard, the detection of
PrPSc within the CNS of clinically normal
young adult ARR/ARR sheep diagnosed with
atypical scrapie should be noted [14]. Fur-
thermore, the recent preliminary observation
of two ARR/ARR sheep with clinical scrapie
that is readily transmissible to mice [17], sup-
ports the view that there may be no ovine
PrP genotype with absolute resistance to TSE.
Long standing transgenic studies in scrapie
infected mice [34] would predict that prions
derived from subclinical or clinical infections
of ARR/ARR sheep may be transmissible to
healthy sheep of the same PrP genotype. If
this is the case in practice, then care must be
taken to avoid unintentionally creating popu-
lations with only one PrP genotype, even if
it is ARR/ARR. Our current understanding
from large scale surveillance is that ARR/ARR
clinical scrapie is a very rare phenomenon,
however the above arguments underline the
need for the continued surveillance and the
vigorous application of scrapie control mea-
sures, both genetic and non-genetic.
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9. CONCLUSION
The National Scrapie Plan for Great Britain
has been a successful exercise and, along with
similar programmes in other European coun-
tries, it demonstrates that industry-wide selec-
tion on PrP genotype is feasible. The voluntary
Ram Genotyping Scheme has attracted partic-
ipation from the majority of ram producers.
With the help of the genotyping and selective
culling programmes applied to aﬀected flocks,
it appears that scrapie is being brought un-
der control. However, this conclusion should
be reassessed at a future date when suﬃcient
time has elapsed for the changes in PrP geno-
type profile to penetrate widely throughout the
sheep industry and impact on scrapie risks.
The potential dangers of drastically reduc-
ing PrP genetic diversity in the national sheep
flock have been widely recognized. Primar-
ily these risks are associated with novel TSE
agents that are as yet unknown but may emerge
in the future, as discussed above, and the pos-
sible loss of favourable attributes of a breed
either through linkage or pleiotropic eﬀects
when selecting on a specific PrP alleles. To
guard against this risk, semen gene banks have
been proposed and designed [31], and now
implemented in Great Britain and Northern
Ireland, to provide the potential for future rein-
troduction of removed alleles or genotypes.
Further, these semen banks have been de-
signed accounting for the specific population
dynamics and demographics of each sector of
the UK sheep industry.
These semen banks are particularly impor-
tant in the potential case of the evolution of
new forms of scrapie, in response to changes
in the host population genotype profile. How-
ever, such arguments also warn against taking
a population towards homogeneity, i.e. all an-
imals having the same PrP genotype, as such
a population would be particularly susceptible
to a form of scrapie adapted to this genotype,
and it would no longer be possible to select for
resistance using PrP genotype. In fact, this is
a generalization of the potential disease risks
incurred in genetically homogenous popula-
tions [35]. Therefore, a suitable endpoint for
a breeding programme based on PrP genotype
is one where currently susceptible alleles are
at a low frequency, but a good mix remains of
other alleles.
One last means of guarding against future
risks whilst increasing the resistance of the
population to classical scrapie is to identify
and utilize genes other than PrP that contribute
to scrapie resistance. Evidence for such eﬀects
now exists in the mouse [21,22,25,26,36], cat-
tle [19, 41], and sheep [12]6. Identification of
the genes underlying this genetic variation in
TSE resistance may allow selection for scrapie
resistance that is eﬀective against a wide vari-
ety of scrapie strains. This is an area urgently
requiring further research.
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